Extracellular Matrix-derived Peptide Binds to αvβ3 Integrin and Inhibits Angiogenesis

This publication has 33 references indexed in Scilit:

• The α3(IV)185–206 Peptide from Noncollagenous Domain 1 of Type IV Collagen Interacts with a Novel Binding Site on the β3Subunit of Integrin αvβ3 and Stimulates Focal Adhesion Kinase and Phosphatidylinositol 3-Kinase Phosphorylation
  Journal of Biological Chemistry, 2000
• Fibrosis and angiogenesis
  Current Opinion in Nephrology and Hypertension, 2000
• Cloning, Expression, andin VitroActivity of Human Endostatin
  Biochemical and Biophysical Research Communications, 1999
• Inhibition of mesangial cell proliferation by E2F decoy oligodeoxynucleotide in vitro and in vivo.
  Journal of Clinical Investigation, 1998
• The Goodpasture Autoantigen
  Published by Elsevier ,1996
• COLLAGENS: Molecular Biology, Diseases, and Potentials for Therapy
  Annual Review of Biochemistry, 1995
• Integrin αvβ3 antagonists promote tumor regression by inducing apoptosis of angiogenic blood vessels
  Cell, 1994
• Angiostatin: A novel angiogenesis inhibitor that mediates the suppression of metastases by a lewis lung carcinoma
  Cell, 1994
• Requirement of Vascular Integrin α _v β ₃ for Angiogenesis
  Science, 1994
• Identification of a multifunctional, cell-binding peptide sequence from the a1(NC1) of type IV collagen.
  The Journal of cell biology, 1990